Related Experiment Videos
[Liposomes mediated plasmids encoding human endostatin inhibits endothelial cell proliferation]
Wei Wang1, Xiao-guang Niu, Li-Xin Xie
1Shandong Eye Institute and Hospital, Qingdao 266071, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|August 18, 2004
Summary
Liposomes effectively deliver endostatin (ES) plasmids to endothelial cells, significantly inhibiting their proliferation and altering cell cycle phases. This demonstrates a promising gene therapy approach for controlling endothelium growth.
Area of Science:
- Molecular Biology
- Gene Therapy
- Cell Biology
Context:
- Endothelial cell proliferation is crucial in various physiological and pathological processes.
- Gene delivery systems are essential for targeted therapeutic interventions.
- Endostatin is a known inhibitor of angiogenesis.
Purpose:
- To assess the efficacy of liposome-mediated delivery of endostatin-encoding plasmids.
- To evaluate the impact of endostatin expression on endothelial cell proliferation.
- To analyze the cell cycle effects of endostatin in endothelial cells.
Summary:
- Cationic liposomes successfully delivered the endostatin (ES) plasmid (PCDNA(3)-ES) to Cos-7 and human umbilical vein endothelial cells (ECV-304).
- ES protein expression was confirmed in transfected cells and supernatant.
- Transfection with ES-encoding plasmids inhibited ECV-304 cell proliferation and induced cell cycle arrest at the G(0)/G(1) phase.
Impact:
- Liposome-mediated gene transfer of endostatin provides a viable method for inhibiting endothelial cell proliferation.
- This approach holds potential for therapeutic strategies targeting angiogenesis-dependent diseases.
- Understanding the cell cycle modulation by endostatin offers insights into its anti-proliferative mechanisms.